Krka of Slovenia Says Net Income Drops 3% to 90.1 Million Euros

Krka Group d.d., Slovenia’s biggest drugmaker, said first-half net income fell 3 percent to 90.1 million euros ($110 million).

Sales rose 7 percent in the period to 565.3 million euros from a year earlier, the Novo Mesto-based company said in regulatory filing today.

Krka’s full-year profit target is 170 million euros on sales of 1.13 billion euros, the company said in the statement.

To contact the reporter on this story: Gordana Filipovic in Belgrade at gfilipovic@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.